Treatment progress of malignant lymphoma：reports from the 57th American Society of Hematology annual meeting
10.3760/cma.j.issn.1009-9921.2016.02.003
- VernacularTitle:恶性淋巴瘤治疗进展：第57届美国血液学会年会报道
- Author:
Donglu ZHAO
;
Jun MA
- Publication Type:Journal Article
- Keywords:
Malignant lymphoma;
Chimeric antigen receptor T cell;
Programmed death 1;
American Society of Hematology annual meeting
- From:
Journal of Leukemia & Lymphoma
2016;25(2):72-74
- CountryChina
- Language:Chinese
-
Abstract:
In recent years, there has been significant progress in the treatment of malignant lymphoma, new drugs and new treatment strategies continue to emerge, such as chimeric antigen receptor (CAR) T cells immunotherapy. The issue of malignant lymphoma has received a lot of attention. The recent progress of malignant lymphoma reported in the 57th American Society of Hematology annual meeting were briefly introduced in this article.
